Vinflunine and Capecitabine in Treating Patients With Previously Treated Metastatic Breast Cancer
Study Information
Alliance Study ID: NCCTG-N0632
NCT Study ID (ClinicalTrials.gov): NCT00450515
Disease or Cancer Type: Breast Cancer
Alliance Study Chair: Alvaro Moreno, MD
Status: WITHDRAWN
Study Description
RATIONALE: Drugs used in chemotherapy, such as vinflunine and capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells.
PURPOSE: This phase II trial is studying how well giving vinflunine together with capecitabine works in treating patients with previously treated metastatic breast cancer.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information